Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension – A Multi-Center Randomized Study (Q58371204)
Jump to navigation
Jump to search
article by Edo Kaluski et al published 17 September 2007 in Cardiology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension – A Multi-Center Randomized Study |
article by Edo Kaluski et al published 17 September 2007 in Cardiology |
Statements
Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension – A Multi-Center Randomized Study (English)
0 references
17 September 2007
0 references
109
0 references
4
0 references
273-280
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference